OrbusNeich names Denise Lau co-CEO alongside David Chien

PUBT · 2d ago
OrbusNeich names Denise Lau co-CEO alongside David Chien
  • OrbusNeich Medical named Executive Director Kwai Ching Denise Lau as co-CEO, effective Aug. 17, 2026.
  • Lau stepped down as chief operating officer; she previously led group operations and joined in 2018 as general counsel.
  • Executive Director Wing Shing Chen became chief operating officer, replacing his prior roles as CFO and company secretary.
  • Chen previously served as CFO since 2018; he joined in 2017 as financial controller following a career at PwC.
  • Man Ying Chan was appointed CFO and company secretary; she previously held the same roles at Hong Kong-listed companies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrbusNeich Medical Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12286075), on August 17, 2026, and is solely responsible for the information contained therein.